| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|
Adverse Drug Event
[description not available] | 0 | 4.39 | 1 | 1 |
Carcinoma, Non-Small Cell Lung
[description not available] | 0 | 5.85 | 4 | 2 |
Cancer of Lung
[description not available] | 0 | 5.85 | 4 | 2 |
Carcinoma, Non-Small-Cell Lung
A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. | 1 | 7.85 | 4 | 2 |
Lung Neoplasms
Tumors or cancer of the LUNG. | 0 | 5.85 | 4 | 2 |
Drug-Related Side Effects and Adverse Reactions
Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals. | 0 | 4.39 | 1 | 1 |
Metastase
[description not available] | 0 | 5.06 | 3 | 3 |
Neoplasm Metastasis
The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. | 0 | 5.06 | 3 | 3 |
Cancer of Ovary
[description not available] | 0 | 10.26 | 11 | 11 |
Peripheral Nerve Diseases
[description not available] | 0 | 9.88 | 11 | 9 |
Androgen-Independent Prostatic Cancer
[description not available] | 0 | 9.7 | 9 | 9 |
Ovarian Neoplasms
Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. | 1 | 12.26 | 11 | 11 |
Peripheral Nervous System Diseases
Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves. | 0 | 9.88 | 11 | 9 |
Prostatic Neoplasms, Castration-Resistant
Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE. | 1 | 11.7 | 9 | 9 |
Benign Neoplasms
[description not available] | 0 | 6.53 | 6 | 3 |
Neoplasms
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. | 1 | 8.53 | 6 | 3 |
Benign Neoplasms, Brain
[description not available] | 0 | 6.66 | 4 | 3 |
Brain Neoplasms
Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. | 0 | 6.66 | 4 | 3 |
Glial Cell Tumors
[description not available] | 0 | 4.35 | 1 | 1 |
Glioma
Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) | 0 | 4.35 | 1 | 1 |
Bone Cancer
[description not available] | 0 | 2.05 | 1 | 0 |
Bone Loss, Osteoclastic
[description not available] | 0 | 3.85 | 2 | 1 |
Osteolysis
Dissolution of bone that particularly involves the removal or loss of calcium. | 0 | 2.05 | 1 | 0 |
Experimental Mammary Neoplasms
[description not available] | 0 | 2.05 | 1 | 0 |
Bone Neoplasms
Tumors or cancer located in bone tissue or specific BONES. | 0 | 2.05 | 1 | 0 |
Cachexia
General ill health, malnutrition, and weight loss, usually associated with chronic disease. | 0 | 2.05 | 1 | 0 |
Disease Exacerbation
[description not available] | 0 | 6.44 | 3 | 3 |
Breast Cancer
[description not available] | 0 | 5.33 | 2 | 2 |
Lassitude
[description not available] | 0 | 4.36 | 1 | 1 |
Nervous System Disorders
[description not available] | 0 | 4.36 | 1 | 1 |
Breast Neoplasms
Tumors or cancer of the human BREAST. | 1 | 8.93 | 4 | 4 |
Fatigue
The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli. | 0 | 4.36 | 1 | 1 |
Nervous System Diseases
Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. | 0 | 4.36 | 1 | 1 |
Malignant Melanoma
[description not available] | 0 | 3.44 | 1 | 1 |
Melanoma
A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) | 1 | 5.44 | 1 | 1 |
Disease Models, Animal
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. | 0 | 3.45 | 1 | 1 |
Age-Related Osteoporosis
[description not available] | 0 | 3.45 | 1 | 1 |
Osteoporosis
Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. | 0 | 3.45 | 1 | 1 |
Anaplastic Astrocytoma
[description not available] | 0 | 4.37 | 1 | 1 |
Astrocytoma, Grade IV
[description not available] | 0 | 4.37 | 1 | 1 |
Local Neoplasm Recurrence
[description not available] | 0 | 4.37 | 1 | 1 |
Astrocytoma
Neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. Fibrillary astrocytomas are the most common type and may be classified in order of increasing malignancy (grades I through IV). In the first two decades of life, astrocytomas tend to originate in the cerebellar hemispheres; in adults, they most frequently arise in the cerebrum and frequently undergo malignant transformation. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2013-7; Holland et al., Cancer Medicine, 3d ed, p1082) | 0 | 4.37 | 1 | 1 |
Glioblastoma
A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures. | 1 | 6.37 | 1 | 1 |
Recrudescence
[description not available] | 0 | 4.37 | 1 | 1 |
Body Weight
The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. | 0 | 2.07 | 1 | 0 |
Encephalopathy, Toxic
[description not available] | 0 | 2.07 | 1 | 0 |
Cancer of Prostate
[description not available] | 0 | 4.37 | 1 | 1 |
Prostatic Neoplasms
Tumors or cancer of the PROSTATE. | 0 | 4.37 | 1 | 1 |